DEC 04, 2015 1:35 PM PST

Pump Thrombosis - Is It On the Rise or Not?

WRITTEN BY: Kara Marker
For patients with weak hearts that need help pumping blood, an alternative to a heart transplant is an implant of a mechanical pump, called a left ventricular assist device (LVAD). These devices help the heart move blood from the chambers to the body tissues, supporting heart function and blood flow (National Heart, Lung, and Blood Institute). However, these machines are just as prone to error as an actual human heart, and 2011 saw a rise in LVAD malfunction that resulted in dangerous blood clots. 

More LVADs than actual human hearts are currently received by patients with heart failure. Blockages can occur inside the LVAD, called pump thrombosis, potentially inducing a state of "inadequte circulatory support or death" (American Association for Thoracic Surgery). A recent study published in The Journal of Heart and Lung Transplantation (JHLT) looked at whether the number of pump thrombosis cases has decreased since the spike in 2011, and the results were partly inconclusive. 

Various theories explaining LVAD pump thrombosis rates are proposed by medical professionals. Two different studies from two different research were presented in the JHLT. From the University of Alabama at Birmingham, results indeed showed a surge of pump thrombosis risk betwen 2011 and 2013 but a decline starting in the first half of 2014. However, an independent study from the Cleveland Clinic did not show any decline in 2014. 

It is still unclear whether the risk of pump thrombosis has decreased at any time since 2011, and doctors are not stopping the search for an explanation behind the pump thrombosis, focusing heavily on potential treatments.

In a study on pump thrombosis treatment, associates from the Mechanical Circulatory Support Research Network observed "anti-clotting and clot-dissolving drugs were unsuccessful in half of the cases," while "pump replacement was uniformaly successful."

While the search continues for an explanation and/or confirmation of whether clot risk is decreasing for LVAD users, the potential risks must be communicated to patients who are being considered for receiving an LVAD.

"Is there a glimmer of hope in reducing risk of pump thrombosis with newer devices?" asked researchers and doctors from Brigham and Women’s Hospital and Harvard Medical School. “Engineering progress along with a better understanding of hemocompatibility will undoubtedly help to reduce the problem of pump thrombosis and will allow the expansion of mechanical circulatory support into broader groups of patients. Until then we must redouble our efforts to ensure that today's patients live longer and better with approved pump technology even as we look with hope to the future."

Watch the following video to see an animation showing how the LVAD works.

Source: Medical News Today 

 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 29, 2019
Cardiology
MAY 29, 2019
The Link Between Uterine Fibroids And Cardiovascular Disease
Uterine fibroids are generally benign tumors of the smooth muscle within the uterus. In females, they are the most common tumor type. Fibroids become more ...
JUL 16, 2019
Cardiology
JUL 16, 2019
Probiotics For Hypertension May Become Standard
Today, as it is relatively new frontier within scientific research, the role of the microbiome is up for debate. As scientists grow increasingly more inter...
AUG 08, 2019
Cardiology
AUG 08, 2019
The Best Way to Test Blood Pressure and Find Heart Disease
Heart disease causes hundreds of thousands of deaths annually -- can a new study on blood pressure tests guide doctors toward earlier diagnosis? About one ...
SEP 04, 2019
Health & Medicine
SEP 04, 2019
Are You Getting Enough Heart-Healthy Sleep?
Is there a sleep duration sweet spot to decrease your risk of heart attacks? According to researchers from the University of Colorado: Boulder, there is! T...
OCT 09, 2019
Drug Discovery & Development
OCT 09, 2019
Drug Increases Survival Rates for Heart Failure Patients
Scientists have demonstrated in preclinical studies that a drug called ‘Aliskiren’ works by inhibiting the activity of an enzyme involved in bl...
NOV 01, 2019
Clinical & Molecular DX
NOV 01, 2019
myTAIHEART Blood Test and Biopsy of Heart Transplant Recipients
Transplant rejection is a process where the immune system of the patient consider the donor's organ as foreign and rejects them. This is because t...
Loading Comments...